Technical Feasibility Study of a Novel Wearable Capnograph (MARIE) in an Emergency Care Environment, Part 1
Launched by UPPSALA UNIVERSITY · Mar 25, 2025
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new device that can measure the levels of carbon dioxide in your breath while you're being transported by ambulance to the hospital. The goal is to see if this device can help paramedics monitor your health better and start treatment sooner. If you are chosen to participate, you will be part of a project aiming to improve how patients are monitored during ambulance rides, which could lead to better care in emergency situations.
To be eligible for this trial, you need to be between 18 and 84 years old. This includes healthy volunteers and patients who are being taken to the hospital by ambulance. However, if you are in a critical condition, need extra oxygen, are pregnant, or cannot provide consent, you won't be able to participate. If you join, you can expect to have your carbon dioxide levels monitored along with other usual checks like blood pressure and pulse during your ambulance ride. This research has been approved by an ethical review board to ensure that it's safe and appropriate for participants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 20 healthy volunteers 18-84 years
- • 30 patients between 18-84 years being transported by ambulance
- Exclusion Criteria:
- • Priority 1 ambulance transports
- • Patients needing oxygen supply
- • Known pregnancy
- • Patients unable to provide informed consent
About Uppsala University
Uppsala University, a prestigious institution located in Sweden, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive expertise in various fields of health sciences to conduct innovative studies aimed at improving patient outcomes and understanding complex diseases. With a strong emphasis on ethical standards and rigorous scientific methodologies, Uppsala University collaborates with a network of researchers, healthcare professionals, and industry partners to facilitate groundbreaking clinical trials that contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Uppsala, , Sweden
Patients applied
Trial Officials
David Smekal, MD, PhD, docent
Principal Investigator
Department of Surgical Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported